GGrantIndex
← Search

Winship Cancer Institute Cancer Center Support Grant

$60,000P30FY2021CANIH

Emory University, Atlanta GA

Investigators

Linked publications, trials & patents

Trial NCT07405476Trial NCT07213154Trial NCT07174570Trial NCT07155317Trial NCT07150546Trial NCT07140679Trial NCT07112690Trial NCT07104240Trial NCT07101445Trial NCT06914999Trial NCT06868433Trial NCT06865768Trial NCT06799481Trial NCT06760507Trial NCT06731270Trial NCT06709534Trial NCT06708351Trial NCT06674863Trial NCT06662058Trial NCT06650579Trial NCT06636734Trial NCT06595160Trial NCT06583148Trial NCT06541158Trial NCT06534125Trial NCT06495125Trial NCT06492759Trial NCT06492070Trial NCT06423326Trial NCT06328699Trial NCT06328686Trial NCT06324240Trial NCT06254911Trial NCT06132685Trial NCT06105918Trial NCT06008730Trial NCT06006013Trial NCT05998135Trial NCT05877859Trial NCT05873608Trial NCT05798507Trial NCT05779943Trial NCT05756569Trial NCT05733351Trial NCT05526872Trial NCT05514912Trial NCT05513859Trial NCT05506982Trial NCT05493566Trial NCT05488145Trial NCT05464810Trial NCT05391750Trial NCT05387915Trial NCT05368428Trial NCT05346692Trial NCT05341349Trial NCT05320406Trial NCT05315687Trial NCT05310448Trial NCT05274763Trial NCT05250895Trial NCT05245682Trial NCT05244239Trial NCT05208307Trial NCT05204160Trial NCT05103904Trial NCT05091866Trial NCT05086731Trial NCT05039073Trial NCT05017610Trial NCT04908709Trial NCT04895592Trial NCT04890236Trial NCT04883437Trial NCT04878029Trial NCT04848519Trial NCT04776395Trial NCT04762199Trial NCT04754945Trial NCT04750473Trial NCT04731376Trial NCT04725903Trial NCT04676087Trial NCT04590664Trial NCT04585724Trial NCT04524702Trial NCT04483206Trial NCT04433949Trial NCT04428671Trial NCT04393350Trial NCT04366791Trial NCT04361552Trial NCT04352205Trial NCT04348292Trial NCT04340882Trial NCT04278118Trial NCT04276194Trial NCT04262869Trial NCT04191421Trial NCT04144127

Abstract

PROJECT SUMMARY/ABSTRACT - Cancer Clinical Investigator Team Leadership Award (CCITLA) Dr. Eaton is an academic radiation oncologist with a research focus on therapeutic clinical trial development involving novel approaches of radiotherapy for pediatric and adult brain tumor patients. Her goal is to lead institutional investigator-initiated and NCI-funded cooperative group clinical trials that will further advance the fight against cancer. Dr. Eaton plays a critical role in Winship Cancer Institute's clinical trial program and is extensively involved in NCI funded clinical trials. She is as an active member in multiple national committees of NRG Oncology and the Children's Oncology Group (COG), and the Pediatric Brain Tumor Consortium (PBTC). She is the institutional principal investigator of two NCI-funded clinical trials through NRG Oncology and five investigator initiated clinical trials at Winship, and contributes as an active co-investigator on numerous others. As a radiation oncology leader among the Winship brain tumor pediatric oncology programs, Dr. Eaton is an important contributor to patient enrolment to NCTN trials at Winship, playing a major role in the Winship Lead Academic Participating Site (LAPS award) award from the NCI. She is an integral member of Winship's Clinical and translational Research Committee (CTRC) and serves as the Pediatric Medical Director of the Emory Proton Therapy Center (EPTC), which opened in 2018 as the first proton center in the state of Georgia. In this role, Dr. Eaton led the EPTC Imaging and Radiation Oncology Core (IROC) credentialing process necessary for participation in NCTN clinical trials, critical to the successful opening of 12 NCI funded clinical trials at EPTC and supporting NCTN clinical trial accrual with the adoption of this advanced technology in the state of Georgia. Winship Cancer Institute of Emory University fully supports Dr. Eaton in her career goals to advance as a national leader in clinical trials for brain tumor patients and pediatric malignancies, and in her ongoing efforts to enhance the clinical trial program at Winship. The CCITLA award will support protected time for Dr. Eaton to focus on key initiatives that will develop infrastructure and process improvements to expand clinical trials and increase trial accrual at Winship, and further develop her own promising protocol concepts at the national level. The CCITLA funding mechanism will undoubtedly help foster academic growth and lead to further leadership roles within the Department of Radiation Oncology, Winship Cancer Institute, Emory University, as well as the NCI Trial Networks.

View original record on NIH RePORTER →